3 results
Primary:* To describe the effect of the new thermo stable formulation of FLOLAN on quality of life in patients switching from the currently marketed FLOLAN to the new thermo stable formulation.* To determine the dose titration requirementSecondary…
To assess the rates of preliminary response and sustained remission of AASV following rituximab (on the basis of former studies, 86% sustained remission expected with rituximab compared to 75% in control group).To assess safety of a rituximab…
To demonstrate the safety, feasibility and performance of the EnSite HD Grid Catheter mapping system for advanced high-density three-dimensional mapping in patients undergoing catheter ablation procedures for the treatment of non-paroxysmal atrial…